Stock screenerAll disclosures →
EDGAR →
ELAB
Conviction 4HealthcareScan · Thu, Jun 25, 2026ELAB$1.17-6.40%
ResistanceSupportVol 14Vol MA14 2.5M
Mar 26Apr 14May 1May 19Jun 8Jun 25
WSB mentions · 24h changelatest +1100.00%· 12 mentions
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.17
Change-6.40%
Gap-0.40%
Rel volume0.10×
Avg volume2.72M
Avg $ vol4.42M
SMA 201.52
SMA 502.05
SMA 2003.63
Price vs 50-42.89%
Price vs 200-67.79%
MA stackbearish
50/200 cross—
Supertrenddown · 1.61
RSI (14)32
MACD hist0.01
MACD cross—
Stoch %K / %D2 / 4
ADX (14)10
+DI / −DI18 / 28
RSI divergence—
MACD divergence—
ATR %+15.64%
ADR %9.08%
52w high14.00
52w low0.7055
From 52w high-91.64%
Above 52w low+65.84%
New 52w highNo
SqueezeOn · 29d
Bollinger width51.13%
%B0.05
Donchian pos1.23%
Donchian high1.97
Donchian low1.16
AVWAP (52w high)5.22
vs AVWAP high-77.58%
AVWAP (52w low)4.71
vs AVWAP low-75.15%
OBV trendUp
Chaikin MF (20)0.16
Today vs 20d0.10×
Avg vol (14d)2.5M
Avg vol (20d)2.72M
Avg $ vol (20d)4.42M
Market cap5.32M
RS 3m (vs SPY)-69.00%
RS 6m (vs SPY)-52.43%
RS line new highNo
Trend template1/8
Technical rank6.1
1 week-18.18%
1 month-33.14%
3 months-35.71%
6 months-41.79%
1 year-46.33%
YTD-17.61%
P/E-0.69
P/B0.42
P/S9.01
P/FCF-0.83
EPS-0.4000
Div yield—
ROE-61.46%
ROA-29.76%
Debt/Eq—
Current1.45
EV/EBITDA—
Gross margin31.40%
Net margin—
Rev growth-65.54%
EPS growth-24.05%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value1.33M
Revenue681.99K
Net income-4.97M
Gross profit230.47K
Free cash flow-6.38M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.54M
Employees34
ListedTue, Nov 21, 2023
Free float1.18M
Float %99.9%
Short interest600.48K
Days to cover0.4d
Short volume42.9%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank6.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance2.34
Support1.50
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ELAB
No recent disclosed trades by Congress in ELAB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ELAB · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bensler Graydon Chief Executive Officer · Options · 2026-06-01 | Grant | 450.28K | $0 | 2026-06-01 | 2026-06-03 |
Parry Jeffrey Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-03 |
Daley Juliana Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-02 |
Kovalyov George Director · Options · 2026-06-01 | Grant | 75.05K | $0 | 2026-06-01 | 2026-06-02 |
Braeden Lichti Director · Options · 2026-06-01 | Grant | 450.28K | $0 | 2026-06-01 | 2026-06-02 |
SEC filings
EDGAR filings in ELAB · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.